Morning Buzz: Exelixis, Inc. (EXEL), Alimera Sciences Inc (ALIM), Dreamworks Animation (DWA)

Shares of Exelixis, Inc. (EXEL) are up almost 23% to $1.91 in pre-market trading Monday after the company announced positive results from coBRIM, the phase 3 pivotal trial of cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib in previously untreated patients with BRAF V600 Mutation-positive advanced melanoma. Exelixis, Inc. shares have […] View the full post at: Morning Buzz: Exelixis, Inc. (EXEL), Alimera Sciences Inc (ALIM), Dreamworks Animation (DWA) No related posts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.